POSITRON EMISSION TOMOGRAPHY AGENT FOR IMAGING VULNERABLE ATHEROSCLEROTIC PLAQUE AND MANUFACTURING METHOD THEREOF

The present invention relates to a compound labeled with a radioactive isotope used in positron emission tomography (PET), for imaging an atherosclerotic plaque, which is a cause of a cardio-cerebrovascular disease, and to a manufacturing method, and to an application thereof. More specifically, two to four peptides which are labeled with the radioactive isotope, and capable of selectively targeting the atherosclerotic plaque are combined, with a small amount and for a short period of time, to an arterial plaque in arteries in which blood flows fast. Therefore, the present invention relates to the compound which can produce excellent PET images, to the manufacturing method, and to the application thereof..

Medienart:

Patent

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Europäisches Patentamt - (2017) vom: 08. März Zur Gesamtaufnahme - year:2017

Sprache:

Englisch

Beteiligte Personen:

CHI DAE YOON [VerfasserIn]
LEE BYOUNG SE [VerfasserIn]
CHU SO YOUNG [VerfasserIn]
CHANG KI YUK [VerfasserIn]
O JOO HYUN [VerfasserIn]
PARK HYO EUN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61B: Diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000)
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
Che
Med

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2017-03-08, Last update posted on www.tib.eu: 2022-05-29, Last updated: 2023-02-09

Patentnummer:

KR20170025337

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA008287317